Skylands Capital Raised Asure Software (ASUR) Position by $1.15 Million; Valuation Declined; As Pfizer (PFE) Stock Value Declined, Shareholder Jones Collombin Investment Counsel Has Cut Position

April 21, 2018 - By Richard Conner

Pfizer Inc. (NYSE:PFE) Logo

Charles Paquelet increased its stake in Asure Software Inc (ASUR) by 42.96% based on its latest 2017Q4 regulatory filing with the SEC. Skylands Capital Llc bought 82,227 shares as the company’s stock declined 3.36% with the market. The hedge fund run by Charles Paquelet held 273,650 shares of the edp services company at the end of 2017Q4, valued at $3.86 million, up from 191,423 at the end of the previous reported quarter. Skylands Capital Llc who had been investing in Asure Software Inc for a number of months, seems to be bullish on the $190.02M market cap company. The stock decreased 0.53% or $0.08 during the last trading session, reaching $15.1. About 219,610 shares traded or 43.48% up from the average. Asure Software, Inc. (NASDAQ:ASUR) has risen 25.51% since April 21, 2017 and is uptrending. It has outperformed by 13.96% the S&P500.

Jones Collombin Investment Counsel Inc decreased its stake in Pfizer Inc (PFE) by 5.81% based on its latest 2017Q4 regulatory filing with the SEC. Jones Collombin Investment Counsel Inc sold 15,230 shares as the company’s stock declined 3.13% with the market. The institutional investor held 246,915 shares of the health care company at the end of 2017Q4, valued at $8.94M, down from 262,145 at the end of the previous reported quarter. Jones Collombin Investment Counsel Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $217.90 billion market cap company. The stock increased 0.27% or $0.1 during the last trading session, reaching $36.63. About 21.23M shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 21, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Jones Collombin Investment Counsel Inc, which manages about $304.23 million US Long portfolio, upped its stake in Teck Resources Ltd (NYSE:TCK) by 33,460 shares to 271,710 shares, valued at $7.11 million in 2017Q4, according to the filing. It also increased its holding in Methanex Corp (NASDAQ:MEOH) by 57,730 shares in the quarter, for a total of 99,540 shares, and has risen its stake in Csx Corp (NYSE:CSX).

Investors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It improved, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Moreover, Lagoda Mgmt Lp has 0.02% invested in Pfizer Inc. (NYSE:PFE). Amp Investors Limited stated it has 2.10M shares. 8,503 were reported by Boston Common Asset Limited Com. Comerica Securities Incorporated has invested 0.5% in Pfizer Inc. (NYSE:PFE). Balasa Dinverno Foltz Limited Liability Corporation reported 44,470 shares stake. Tctc Hldgs Lc reported 1.98% stake. Hays Advisory invested in 0.13% or 10,218 shares. Miracle Mile Ltd holds 8,000 shares. Principal Fincl Inc holds 14.99 million shares. Taylor Frigon Cap Management Lc, California-based fund reported 28,114 shares. Winslow Asset Management Inc accumulated 0.13% or 19,111 shares. Chelsea Counsel has 0.11% invested in Pfizer Inc. (NYSE:PFE) for 5,642 shares. Carret Asset Ltd Liability reported 124,557 shares. Commerce Comml Bank has 2.71 million shares. Moreover, Wagner Bowman Mngmt Corporation has 0.53% invested in Pfizer Inc. (NYSE:PFE) for 55,034 shares.

Since December 15, 2017, it had 0 insider purchases, and 12 insider sales for $12.99 million activity. 50,000 shares were sold by LANKLER DOUGLAS M, worth $1.84M. Another trade for 64,587 shares valued at $2.39M was made by Dolsten Mikael on Monday, February 26. JOHNSON RADY A also sold $296,560 worth of Pfizer Inc. (NYSE:PFE) shares. On Tuesday, March 6 the insider HILL CHARLES H sold $1.52 million. $1.24M worth of Pfizer Inc. (NYSE:PFE) was sold by SUSMAN SALLY on Monday, February 26. 1,758 Pfizer Inc. (NYSE:PFE) shares with value of $64,679 were sold by CORNWELL W DON.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 78 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Neutral” rating on Wednesday, November 25 by SunTrust. The stock has “Buy” rating by BMO Capital Markets on Friday, December 15. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, August 1. BMO Capital Markets has “Hold” rating and $3300 target. Credit Suisse maintained the stock with “Outperform” rating in Monday, May 9 report. The rating was downgraded by BMO Capital Markets on Wednesday, November 2 to “Market Perform”. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, January 31. The firm has “Neutral” rating by Morgan Stanley given on Friday, April 7. On Monday, June 12 the stock rating was maintained by BMO Capital Markets with “Hold”. The stock has “Buy” rating by BMO Capital Markets on Tuesday, November 21. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by S&P Research on Wednesday, October 28.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 EPS, up 5.80% or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34 billion for 12.54 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74% EPS growth.

Skylands Capital Llc, which manages about $986.41 million and $776.20 million US Long portfolio, decreased its stake in Core Mark Holding Co Inc (NASDAQ:CORE) by 39,300 shares to 16,500 shares, valued at $521,000 in 2017Q4, according to the filing. It also reduced its holding in Twin Disc Inc (NASDAQ:TWIN) by 15,000 shares in the quarter, leaving it with 59,400 shares, and cut its stake in Nn Inc (NASDAQ:NNBR).

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>